Selected research
Industry Research
Contraceptive Drugs and Devices Industry Research Report 2026
Market perspective
The global Contraceptive Drugs and Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Contraceptive Drugs and Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Contraceptive Drugs and Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Contraceptive Drugs and Devices include Teva Pharmaceutical Industries, Merck, Pfizer, Bayer Healthcare, Warmer Chilcott, Pantarhei Bioscience, Mayer Laboratories, Church & Dwight and BioSante Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Contraceptive Drugs and Devices market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Contraceptive Drugs and Devices Market by Company
Teva Pharmaceutical Industries
Merck
Pfizer
Bayer Healthcare
Warmer Chilcott
Pantarhei Bioscience
Mayer Laboratories
Church & Dwight
BioSante Pharmaceuticals
Agile Therapeutics
Contraceptive Drugs and Devices Segment by Type
Injectable Contraceptive Drugs
Vaginal
Male/Female Contraceptive Devices
Oral
Contraceptive Drugs and Devices Segment by Application
Hospitals
Pharmacies
Others
Contraceptive Drugs and Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drugs and Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drugs and Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drugs and Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Contraceptive Drugs and Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Contraceptive Drugs and Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Contraceptive Drugs and Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injectable Contraceptive Drugs
- Vaginal
- Male/Female Contraceptive Devices
- Oral
Applications
- Hospitals
- Pharmacies
- Others
Companies covered
- Teva Pharmaceutical Industries
- Merck
- Pfizer
- Bayer Healthcare
- Warmer Chilcott
- Pantarhei Bioscience
- Mayer Laboratories
- Church & Dwight
- BioSante Pharmaceuticals
- Agile Therapeutics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Contraceptive Drugs and Devices Market Size (2021-2032)
- 2.2.2 Global Contraceptive Drugs and Devices Sales (2021-2032)
- 2.2.3 Global Contraceptive Drugs and Devices Market Average Price (2021-2032)
- 2.3 Contraceptive Drugs and Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injectable Contraceptive Drugs
- 2.3.3 Vaginal
- 2.3.4 Male/Female Contraceptive Devices
- 2.3.5 Oral
- 2.4 Contraceptive Drugs and Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Pharmacies
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Contraceptive Drugs and Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Contraceptive Drugs and Devices Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Contraceptive Drugs and Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Contraceptive Drugs and Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Contraceptive Drugs and Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Contraceptive Drugs and Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Contraceptive Drugs and Devices, Product Type & Application
- 3.8 Global Manufacturers of Contraceptive Drugs and Devices, Established Date
- 3.9 Global Contraceptive Drugs and Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical Industries
- 4.1.1 Teva Pharmaceutical Industries Company Information
- 4.1.2 Teva Pharmaceutical Industries Business Overview
- 4.1.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio
- 4.1.5 Teva Pharmaceutical Industries Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Contraceptive Drugs and Devices Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Contraceptive Drugs and Devices Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Bayer Healthcare
- 4.4.1 Bayer Healthcare Company Information
- 4.4.2 Bayer Healthcare Business Overview
- 4.4.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio
- 4.4.5 Bayer Healthcare Recent Developments
- 4.5 Warmer Chilcott
- 4.5.1 Warmer Chilcott Company Information
- 4.5.2 Warmer Chilcott Business Overview
- 4.5.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio
- 4.5.5 Warmer Chilcott Recent Developments
- 4.6 Pantarhei Bioscience
- 4.6.1 Pantarhei Bioscience Company Information
- 4.6.2 Pantarhei Bioscience Business Overview
- 4.6.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio
- 4.6.5 Pantarhei Bioscience Recent Developments
- 4.7 Mayer Laboratories
- 4.7.1 Mayer Laboratories Company Information
- 4.7.2 Mayer Laboratories Business Overview
- 4.7.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio
- 4.7.5 Mayer Laboratories Recent Developments
- 4.8 Church & Dwight
- 4.8.1 Church & Dwight Company Information
- 4.8.2 Church & Dwight Business Overview
- 4.8.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Church & Dwight Contraceptive Drugs and Devices Product Portfolio
- 4.8.5 Church & Dwight Recent Developments
- 4.9 BioSante Pharmaceuticals
- 4.9.1 BioSante Pharmaceuticals Company Information
- 4.9.2 BioSante Pharmaceuticals Business Overview
- 4.9.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio
- 4.9.5 BioSante Pharmaceuticals Recent Developments
- 4.10 Agile Therapeutics
- 4.10.1 Agile Therapeutics Company Information
- 4.10.2 Agile Therapeutics Business Overview
- 4.10.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio
- 4.10.5 Agile Therapeutics Recent Developments
5 Global Contraceptive Drugs and Devices Market Scenario by Region
- 5.1 Global Contraceptive Drugs and Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Contraceptive Drugs and Devices Sales by Region: 2021-2032
- 5.2.1 Global Contraceptive Drugs and Devices Sales by Region: 2021-2026
- 5.2.2 Global Contraceptive Drugs and Devices Sales by Region: 2027-2032
- 5.3 Global Contraceptive Drugs and Devices Revenue by Region: 2021-2032
- 5.3.1 Global Contraceptive Drugs and Devices Revenue by Region: 2021-2026
- 5.3.2 Global Contraceptive Drugs and Devices Revenue by Region: 2027-2032
- 5.4 North America Contraceptive Drugs and Devices Market Facts & Figures by Country
- 5.4.1 North America Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Contraceptive Drugs and Devices Sales by Country (2021-2032)
- 5.4.3 North America Contraceptive Drugs and Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Contraceptive Drugs and Devices Market Facts & Figures by Country
- 5.5.1 Europe Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Contraceptive Drugs and Devices Sales by Country (2021-2032)
- 5.5.3 Europe Contraceptive Drugs and Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Contraceptive Drugs and Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Contraceptive Drugs and Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Contraceptive Drugs and Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Contraceptive Drugs and Devices Market Facts & Figures by Country
- 5.7.1 South America Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Contraceptive Drugs and Devices Sales by Country (2021-2032)
- 5.7.3 South America Contraceptive Drugs and Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Contraceptive Drugs and Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Contraceptive Drugs and Devices Sales by Type (2021-2032)
- 6.1.1 Global Contraceptive Drugs and Devices Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Contraceptive Drugs and Devices Revenue by Type (2021-2032)
- 6.2.1 Global Contraceptive Drugs and Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Contraceptive Drugs and Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Contraceptive Drugs and Devices Sales by Application (2021-2032)
- 7.1.1 Global Contraceptive Drugs and Devices Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Contraceptive Drugs and Devices Revenue by Application (2021-2032)
- 7.2.1 Global Contraceptive Drugs and Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Contraceptive Drugs and Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Contraceptive Drugs and Devices Value Chain Analysis
- 8.1.1 Contraceptive Drugs and Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Contraceptive Drugs and Devices Production Mode & Process
- 8.2 Contraceptive Drugs and Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Contraceptive Drugs and Devices Distributors
- 8.2.3 Contraceptive Drugs and Devices Customers
9 Global Contraceptive Drugs and Devices Analyzing Market Dynamics
- 9.1 Contraceptive Drugs and Devices Industry Trends
- 9.2 Contraceptive Drugs and Devices Industry Drivers
- 9.3 Contraceptive Drugs and Devices Industry Opportunities and Challenges
- 9.4 Contraceptive Drugs and Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst